(Q43572222)

24 November 2017

0 references

Ascomycin: an advance in the management of atopic dermatitis (English)

1 reference

24 November 2017

author

Christopher Griffiths

series ordinal

1

1 reference

24 November 2017

language of work or name

English

0 references

publication date

1 April 2001

1 reference

British Journal of Dermatology

24 November 2017

published in

1 reference

24 November 2017

volume

144

1 reference

24 November 2017

issue

4

1 reference

24 November 2017

page(s)

679-681

1 reference

Topical corticosteroid phobia in patients with atopic eczema

24 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2001.144004679.X

Ascomycins: promising agents for the treatment of inflammatory skin diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2001.144004679.X

SDZ ASM 981: an emerging safe and effective treatment for atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2001.144004679.X

First experience of topical SDZ ASM 981 in children with atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2001.144004679.X

A short-term trial of tacrolimus ointment for atopic dermatitis. European Tacrolimus Multicenter Atopic Dermatitis Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2001.144004679.X

FR-900520 and FR-900523, novel immunosuppressants isolated from a Streptomyces. II. Fermentation, isolation and physico-chemical and biological characteristics

21 January 2018

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.7164/ANTIBIOTICS.41.1592

Identifiers

DOI

10.1046/J.1365-2133.2001.144004679.X

1 reference

24 November 2017

1 reference